Counselling support for brain tumour patients and their caregivers

Counselling creates the space for you to talk through your feelings in a safe and confidential place. It will help you to develop strategies for managing your future. It comes into play when support is needed to understand psychological distress associated with, what is sometimes referred to as, “problems with living”.

For example, it may be helpful for someone who is struggling to cope or feeling very anxious or depressed. Counselling tends to have a broader focus and greater depth than coaching. It helps people to explore and understand the feelings which are causing them grief and to identify and explore steps for moving beyond these feelings to make positive changes in their lives.  Counselling can be very challenging as it can often unearth very painful feelings, make people confront unresolved personal issues and challenge them to change the way they go about their lives today and in the future. Counsellors help people by building a supportive relationship which is based on the essential qualities of acceptance/warmth, genuineness and empathy. Like coaching, they do not offer solutions or advice, but instead help the client to identify their own issues and ways of moving forward.

You can download more information about counselling for people affected by brain tumour here.

If you would like to find out more about this service then you can call our helpline on 01983 292 405, or email hello@brainstrust.org.uk

 

We are able to provide fast track access to counselling for people with a brain tumour, and their caregivers thanks to the generous support of Lloyd’s Legacy, and the Souter Charitable Trust.

Discover our resources, designed to help you feel less alone and more in control.

Hypnotherapy for brain tumour patients and their caregivers

When you are living with a brain tumour, or are caring for someone living with a brain tumour, you may find hypnotherapy useful in improving wellbeing in the following areas:

  • Anxiety and stress
  • Diet and lifestyle
  • Resilience, self esteem and confidence
  • Pre and post-operative care
  • Pain management
  • Reduction of side effects from treatment such as nausea, fatigue

We’re delighted to have Louise Baker (MSc Psychology and Neuroscience of Mental Health) working with brainstrust as our own consultant hypnotherapist.

Louise is an experienced trainer of Hypnotherapy, NLP Master Practitioner, coach and Time Line therapist. She holds diplomas in Clinical Hypnotherapy, Hypnotherapy and Psychotherapy and has a Specialist Certificate in Past-Life Regression.

Louise Baker has many years experience as a Clinical Hypnotherapist, having helped hundreds of clients deal with a wide range of issues. She is passionate about hypnotherapy and is really pleased be able to support people affected by a brain tumour.

‘I love helping people change and achieve a sense of well being. By working with me, you can clearly identify what you want and take the steps needed to get there.’

Interested in hypnotherapy or need more information?

Just call brainstrust to discuss your situation in complete confidence 01983 292405 or email hello@brainstrust.org.uk.

Calmness and Connectivity online sessions

Recently retired from 1:1 work, Louise is now focused on bringing the power of this work to groups for brainstrust through our Calmness and Connectivity webinar series.

We are pleased to be able to run two sessions a month, each of them hosted by Louise alongside a brainstrust Support Specialist. We run an afternoon and an evening session- each of which are made up of two parts, to help you gain a deeper understanding of hypnotherapy and practice the techniques discussed in a safe and welcoming environment.

You can find details of the upcoming dates for our Calmness and Connectivity sessions on our events page.

View our upcoming events

If you are interested to read more about what hypnotherapy is and how it may be able to help you when living with a brain tumour diagnosis, take a look at our news article written by brainstrust Support Specialist Jane Gardiner.

What do The Wizard of Oz and our hypnotherapy group sessions have in common?

Did this information make you feel more resourced, more confident or more in control?

Introduction

The Brain Tumour Data Dashboard lets you explore up -to-date, population level data about the brain tumours diagnosed in England between 2013 and 2015. Using the drop down menus on the left you can select different groups of patients to view in the charts below. In these charts the number of patients for every 100 diagnoses is displayed as images of people. Patients have been grouped by date of diagnosis, type of tumour, age, gender, and region in England.

For each group of patients you can explore the different routes to diagnosis, the proportion of those who received chemotherapy or radiotherapy, as well as the survival of the patients within each group. For more information about what these metrics mean please see the glossary.

How to use

  1. Select the year of diagnosis using the drop down menu.
  2. Select your patient group of interest from the four drop down menus in the following order:
    1. Tumour group
    2. Age at diagnosis
    3. Region of England
    4. Gender of patient
  3. To view a second chart to compare different groups of patients, click the ‘compare’ button.The second chart will appear below the first chart.

*Note that the tool is best used on a laptop or tablet rather than a mobile phone*

Unavailable data

Some of the data in these charts is not available.There are two main reasons for this:

  1. How the data has been grouped

If you cannot select a patient group from the drop down menus, the data is unavailable because of how the data has been organised.

Public Health England has grouped the data like a branching tree. The bottom of the tree contains all the patients with brain tumours, and then each branch divides the data by a certain characteristics, like age, or location of tumour. But the data is divided in an order, starting with location of the tumour (endocrine or brain), then by age, region, and gender. Age is at the start because it makes a bigger difference to survival rates and treatment rates than gender or region. Sometimes, after the data has been split by type of tumour and age, there is not enough data to be split again. This is because to protect patient confidentiality groups cannot contain less than 100 patients. Because some groups cannot be split further, you cannot create ‘totals’ for everyone by region or gender. For example, you cannot see results for all ages by region, or all brain tumours by gender. If these totals were calculated and released, it might be possible to identify patients, which is why Public Health England cannot release this data.

  1. Statistical reasons and data availability

If you can select a patient group from the chart menus, but the chart does not display, the data is unavailable for one of several reasons:

  1. Data is not yet available for the selected year from Public Health England.
  2. Data is not available because the data quality is too poor to release this statistic.
  3. Data is not available as the statistic is not appropriate for this group.
  4. Data is not available because the standard error of the estimate was greater than 20% and so the estimate has been supressed.

Up to date brain tumour data

Brain tumour data may influence the decisions you make about your care. Data also helps you understand the bigger picture, or landscape, in which you find yourself.

Brain tumour data and statistics influence the focus, and work of organisations like brainstrust. The information helps us to understand the scale and impact of the problems we are setting out to solve.

This tool helps you understand the landscape in which you find yourself having been diagnosed with a brain tumour. This landscape can be particularly tricky to navigate as there are many different types of brain tumour, all of which have a different impact.

The information you see represents the most up-to-date, official, population level brain tumour data available for England. Over time we will be adding to the brain tumour data available and publishing reports, with recommendations, as a result of what we learn from this data.

The data behind this content has come from Public Health England’s National Cancer Registration and Analysis Service (NCRAS) and is a direct result of the ‘Get Data Out’ project.

This project provides anonymised population level brain tumour data for public use in the form of standard output tables, accessible here: http://cancerdata.nhs.uk/standardoutput

Incidence

The number or rate (per head of population) of new cases of a disease diagnosed in a given population during a specified time period (usually a calendar year). The crude rate is the total number of cases divided by the mid-year population, usually expressed per 100,000 population.

Malignant

Malignant tumours which grow by invasion into surrounding tissues and have the ability to metastasise to distant sites

Mortality

The number or rate (per head of population) of deaths in a given population during a specified time period (usually a calendar year). The crude rate is the total number of deaths divided by the mid-year population, usually expressed per 100,000 population.

Non-malignant

Not cancerousNon-malignant tumours may grow larger but do not spread to other parts of the body.

Survival

The length of time from the date of diagnosis for a disease, such as cancer, that patients diagnosed with the disease are still alive. In a clinical trial, measuring the survival is one way to see how well a new treatment works. Also called ‘overall survival’ or ‘OS’.

Routes to Diagnosis

Under the ‘Routes to Diagnosis’ tab in the Brain Tumour Data Dashboard, you can explore the ways patients have been diagnosed with brain tumours. There are many ways, or routes, for cancers to be diagnosed in the NHS. A ‘route to diagnosis’ is the series of events between a patient and the healthcare system that leads to a diagnosis of cancer. The routes include:

  1. Two Week Wait

Patients are urgently referred by their GP for suspected cancer via the Two Week Wait system and are seen by a specialist within 2 weeks where they are diagnosed.

  1. GP referral

Diagnosis via a GP referral includes routine and urgent referrals where the patient was not referred under the Two Week Wait system.

  1. Emergency Presentation

Cancers can be diagnosed via emergency situations such as via A&E, emergency GP referral, emergency transfer or emergency admission.

  1. Outpatient

Outpatient cancer diagnoses include diagnoses via an elective route which started with an outpatient appointment that is either a self-referral or consultant to consultant referral. (It does not include those under the Two Week Wait referral system).

  1. Inpatient elective

Diagnosis via an inpatient elective route is where diagnosis occurs after the patient has been admitted into secondary care from a waiting list, or where the admission is booked or planned.

  1. Death Certificate Only

Diagnoses made by Death Certificate Only are made where there is no more information about the cancer diagnosis other than the cancer related death notifications. The date of diagnosis is the same as that of the date of death.

  1. Unknown

For some patients with a cancer diagnosis, there is no relevant data available to understand the route to diagnosis.

 

More information

If any of the statistical terms in this section of the brainstrust website are hard to understand, we recommend looking them up here:

Cancer Research UK’s Cancer Statistics Explained

http://www.cancerresearchuk.org/health-professional/cancer-statistics/cancer-stats-explained/statistics-terminology-explained#heading-Seven

If you are looking for help understanding terms relating specifically to brain tumours, and treatment, then the brainstrust glossary is available here:

https://www.brainstrust.org.uk/advice-glossary.php